KeyBanc Starts National Health Investors (NHI) at Hold; Earnings Upside From External Growth, But Concerns Remain
Tweet Send to a FriendGet Alerts NHI Hot Sheet
Price: $61.51 +1.15%
Rating Summary:
1 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
1 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade NHI Now!
KeyBanc initiates coverage on National Health Investors (NYSE: NHI) with a Hold.
KeyBanc analyst says, "Our thesis: External growth upside, solid SNF credit, fairly valued. In the context of an improving economy in 2012, we expect NHI to outperform its health care REIT peers but underperform REITs overall. In our view, the Company offers investors two advantages over other health care REITs. First, we expect NHI to generate substantial earnings upside from accretive investments in 2012...Although uncertainty has recently eased somewhat, we see continued risk of additional government reimbursement and other health care spending cuts. These cuts could negatively impact NHI's property valuations and NAV, as well as the credit of its health care operator tenants."
"We are establishing 2012 and 2013 FFO estimates for NHI of $3.10 and $3.25 per share, respectively."
For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.
Shares of National Health Investors closed at $43.50 yesterday, with a 52 week range of $37.90-$49.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
KeyBanc analyst says, "Our thesis: External growth upside, solid SNF credit, fairly valued. In the context of an improving economy in 2012, we expect NHI to outperform its health care REIT peers but underperform REITs overall. In our view, the Company offers investors two advantages over other health care REITs. First, we expect NHI to generate substantial earnings upside from accretive investments in 2012...Although uncertainty has recently eased somewhat, we see continued risk of additional government reimbursement and other health care spending cuts. These cuts could negatively impact NHI's property valuations and NAV, as well as the credit of its health care operator tenants."
"We are establishing 2012 and 2013 FFO estimates for NHI of $3.10 and $3.25 per share, respectively."
For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.
Shares of National Health Investors closed at $43.50 yesterday, with a 52 week range of $37.90-$49.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
- Raymond James Starts American Residential Properties (ARPI) at Outperform
- Morgan Stanley Starts Quintiles (Q) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
KeyBanc, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
